Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Ikena Oncology, Inc. IKNA |
Citadel Advisors LLC | 2,155,134 5.900% |
26,926 (+1.27%) |
Filing History |
| 2023-02-13 6:11 pm Purchase |
2022-12-31 | 13G | Ikena Oncology, Inc. IKNA |
BIOTECHNOLOGY VALUE FUND L P | 2,503,071 6.900% |
704,700 (+39.19%) |
Filing History |
| 2023-01-10 12:48 pm Purchase |
2023-01-09 | 13G | Ikena Oncology, Inc. IKNA |
FMR LLC | 3,724,575 10.272% |
1,198,372 (+47.44%) |
Filing History |
| 2022-10-11 09:03 am Sale |
2022-10-07 | 13G | Ikena Oncology, Inc. IKNA |
FMR LLC | 2,526,203 6.967% |
-2,197,484 (-46.52%) |
Filing History |
| 2022-02-14 2:57 pm Purchase |
2021-12-31 | 13G | Ikena Oncology, Inc. IKNA |
Omega Fund VI, L.P. | 2,249,123 6.300% |
2,249,123 (New Position) |
Filing History |
| 2022-02-14 1:35 pm Purchase |
2021-12-31 | 13G | Ikena Oncology, Inc. IKNA |
BIOTECHNOLOGY VALUE FUND L P | 1,798,371 5.000% |
198,713 (+12.42%) |
Filing History |
| 2022-02-14 06:12 am Purchase |
2021-12-31 | 13G | Ikena Oncology, Inc. IKNA |
Citadel Advisors LLC | 2,128,208 5.900% |
73,255 (+3.56%) |
Filing History |
| 2022-02-11 5:12 pm Purchase |
2021-03-30 | 13D | Ikena Oncology, Inc. IKNA |
Atlas Venture Fund X, L.P. | 2,901,609 8.100% |
2,901,609 (New Position) |
Filing History |
| 2022-02-09 09:19 am Purchase |
2022-02-08 | 13G | Ikena Oncology, Inc. IKNA |
FMR LLC | 4,723,687 13.155% |
946,049 (+25.04%) |
Filing History |
| 2021-08-16 4:45 pm Unchanged |
2021-08-12 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 1,936,886 5.400% |
0 (Unchanged) |
Filing History |
| 2021-04-14 7:31 pm Purchase |
2021-03-30 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 1,936,886 6.560% |
1,936,886 (New Position) |
Filing History |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | Ikena Oncology, Inc. IKNA |
FMR LLC | 3,777,638 12.541% |
3,777,638 (New Position) |
Filing History |
| 2021-04-09 4:57 pm Purchase |
2021-03-30 | 13G | Ikena Oncology, Inc. IKNA |
Citadel Advisors LLC | 2,054,953 6.600% |
2,054,953 (New Position) |
Filing History |
| 2021-04-05 5:25 pm Purchase |
2021-03-25 | 13G | Ikena Oncology, Inc. IKNA |
BRISTOL MYERS SQUIBB CO BMY |
2,133,142 5.900% |
2,133,142 (New Position) |
Filing History |
| 2021-04-05 5:03 pm Purchase |
2021-03-26 | 13G | Ikena Oncology, Inc. IKNA |
BIOTECHNOLOGY VALUE FUND L P | 1,599,658 5.100% |
1,599,658 (New Position) |
Filing History |